Welcome to LookChem.com Sign In|Join Free

CAS

  • or

78686-01-8

Post Buying Request

78686-01-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

78686-01-8 Usage

Description

1 beta-D-ribofuranosylpyridin-4-one 3-carboxamide is a chemical compound derived from niacin (vitamin B3), featuring a ribofuranosylpyridin-4-one core structure attached to a ribose sugar unit. It plays a crucial role in energy metabolism and serves as a precursor for the synthesis of coenzymes involved in various metabolic pathways. 1 beta-D-ribofuranosylpyridin-4-one 3-carboxamide is also significant for studying nucleic acid metabolism and the activity of enzymes in the biosynthesis of essential coenzymes, making it a vital molecule in both biological and pharmaceutical fields.

Uses

Used in Pharmaceutical Synthesis:
1 beta-D-ribofuranosylpyridin-4-one 3-carboxamide is used as a precursor in the pharmaceutical industry for the synthesis of various pharmaceuticals and chemical compounds. Its unique structure and properties make it a valuable building block for developing new drugs and therapies.
Used in Energy Metabolism:
In the biological field, 1 beta-D-ribofuranosylpyridin-4-one 3-carboxamide is used as a key component in energy metabolism, contributing to the production of energy within cells and the overall functioning of metabolic pathways.
Used in Treatment of Vitamin B3 Deficiencies:
1 beta-D-ribofuranosylpyridin-4-one 3-carboxamide is used as a therapeutic agent for the treatment of conditions such as pellagra and other vitamin B3 deficiencies. Its role in coenzyme synthesis helps address the underlying causes of these deficiencies and improve the health of affected individuals.
Used in Nucleic Acid Metabolism Research:
1 beta-D-ribofuranosylpyridin-4-one 3-carboxamide is used in the study of nucleic acid metabolism, providing insights into the activity of enzymes involved in the biosynthesis of important coenzymes. This research can lead to a better understanding of cellular processes and the development of targeted therapies for various diseases.
Overall, 1 beta-D-ribofuranosylpyridin-4-one 3-carboxamide is a versatile and significant compound with applications in pharmaceutical synthesis, energy metabolism, treatment of vitamin B3 deficiencies, and research on nucleic acid metabolism.

Check Digit Verification of cas no

The CAS Registry Mumber 78686-01-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,8,6,8 and 6 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 78686-01:
(7*7)+(6*8)+(5*6)+(4*8)+(3*6)+(2*0)+(1*1)=178
178 % 10 = 8
So 78686-01-8 is a valid CAS Registry Number.

78686-01-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,5,5-trihydroxypyridine-4-carboxamide

1.2 Other means of identification

Product number -
Other names PCNR compound

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:78686-01-8 SDS

78686-01-8Downstream Products

78686-01-8Relevant articles and documents

Isolation and characterization of an unusual nucleoside, 1-α-D- ribofuranosyl-4-pyridone-3-carboxamide, from the urines of normal human individuals and leukemic patients

Chheda,Patrzyc,Tworek,Dutta

, p. 1519 - 1537 (1995)

A novel modified nucleoside, 1-α-D-Ribofuranosyl-4-pyridone-3- carboxamide, has been isolated from the urines of one normal human individual and two CML patients. The structure was assigned on the basis of UV, NMR and mass spectral data and confirmed by comparison with an authentic sample synthesized in our laboratory. This constitutes the first example of the occurrence of a nucleoside with an α-riboside linkage in human urine.

Monocyclic L-nucleosides, analogs and uses thereof

-

Example 17, (2010/01/31)

Novel monocyclic L- nucleoside compounds have general formula (I). Embodiments of these compounds are contemplated to be useful in treating a wide variety of diseases including infections, infestations, neoplasms, and autoimmune diseases. Viewed in terms of mechanism, embodiments of the novel compounds show immunomodulatory activity, and are expected to be useful in modulating the cytokine pattern, including modulation of Th 1 and Th 2 response.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 78686-01-8